Logo image of MERY.PA

MERCIALYS (MERY.PA) Stock Fundamental Analysis

EPA:MERY - Euronext Paris - Matif - FR0010241638 - REIT - Currency: EUR

10.58  +0.09 (+0.86%)

Fundamental Rating

5

Taking everything into account, MERY scores 5 out of 10 in our fundamental rating. MERY was compared to 41 industry peers in the Diversified REITs industry. MERY has only an average score on both its financial health and profitability. MERY is valued quite cheap, but it does not seem to be growing. These ratings could make MERY a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MERY was profitable.
MERY had a positive operating cash flow in the past year.
Each year in the past 5 years MERY has been profitable.
Each year in the past 5 years MERY had a positive operating cash flow.
MERY.PA Yearly Net Income VS EBIT VS OCF VS FCFMERY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

MERY's Return On Assets of 4.17% is fine compared to the rest of the industry. MERY outperforms 76.74% of its industry peers.
The Return On Equity of MERY (14.26%) is better than 95.35% of its industry peers.
MERY has a better Return On Invested Capital (5.78%) than 76.74% of its industry peers.
Industry RankSector Rank
ROA 4.17%
ROE 14.26%
ROIC 5.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MERY.PA Yearly ROA, ROE, ROICMERY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 33.20%, MERY is doing good in the industry, outperforming 62.79% of the companies in the same industry.
MERY's Profit Margin has declined in the last couple of years.
The Operating Margin of MERY (59.47%) is worse than 67.44% of its industry peers.
MERY's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 95.81%, MERY belongs to the top of the industry, outperforming 88.37% of the companies in the same industry.
In the last couple of years the Gross Margin of MERY has remained more or less at the same level.
Industry RankSector Rank
OM 59.47%
PM (TTM) 33.2%
GM 95.81%
OM growth 3Y-11.46%
OM growth 5Y-8.24%
PM growth 3Y-6.05%
PM growth 5Y-8.66%
GM growth 3Y1.08%
GM growth 5Y0.54%
MERY.PA Yearly Profit, Operating, Gross MarginsMERY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

MERY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for MERY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MERY.PA Yearly Shares OutstandingMERY.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MERY.PA Yearly Total Debt VS Total AssetsMERY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MERY has a debt to FCF ratio of 8.07. This is a slightly negative value and a sign of low solvency as MERY would need 8.07 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 8.07, MERY belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
A Debt/Equity ratio of 1.98 is on the high side and indicates that MERY has dependencies on debt financing.
The Debt to Equity ratio of MERY (1.98) is worse than 90.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 8.07
Altman-Z N/A
ROIC/WACC0.75
WACC7.7%
MERY.PA Yearly LT Debt VS Equity VS FCFMERY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.07 indicates that MERY has no problem at all paying its short term obligations.
MERY's Current ratio of 3.07 is amongst the best of the industry. MERY outperforms 97.67% of its industry peers.
MERY has a Quick Ratio of 3.07. This indicates that MERY is financially healthy and has no problem in meeting its short term obligations.
MERY has a better Quick ratio (3.07) than 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
MERY.PA Yearly Current Assets VS Current LiabilitesMERY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

3

3. Growth

3.1 Past

MERY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.53%.
The Earnings Per Share has been decreasing by -9.96% on average over the past years.
Looking at the last year, MERY shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
Measured over the past years, MERY shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.
EPS 1Y (TTM)7.53%
EPS 3Y-4.69%
EPS 5Y-9.96%
EPS Q2Q%1.75%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y1.39%
Revenue growth 5Y-1.32%
Sales Q2Q%0.86%

3.2 Future

MERY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.29% yearly.
Based on estimates for the next years, MERY will show a small growth in Revenue. The Revenue will grow by 1.88% on average per year.
EPS Next Y2.05%
EPS Next 2Y0.95%
EPS Next 3Y3.29%
EPS Next 5YN/A
Revenue Next Year1.68%
Revenue Next 2Y1.87%
Revenue Next 3Y1.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MERY.PA Yearly Revenue VS EstimatesMERY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
MERY.PA Yearly EPS VS EstimatesMERY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.91 indicates a reasonable valuation of MERY.
Based on the Price/Earnings ratio, MERY is valued a bit cheaper than the industry average as 79.07% of the companies are valued more expensively.
MERY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 9.21, which indicates a very decent valuation of MERY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MERY indicates a somewhat cheap valuation: MERY is cheaper than 72.09% of the companies listed in the same industry.
MERY is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.91
Fwd PE 9.21
MERY.PA Price Earnings VS Forward Price EarningsMERY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MERY indicates a rather cheap valuation: MERY is cheaper than 88.37% of the companies listed in the same industry.
MERY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MERY is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.15
EV/EBITDA 10.47
MERY.PA Per share dataMERY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MERY does not grow enough to justify the current Price/Earnings ratio.
MERY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.31
PEG (5Y)N/A
EPS Next 2Y0.95%
EPS Next 3Y3.29%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.53%, MERY is a good candidate for dividend investing.
MERY's Dividend Yield is rather good when compared to the industry average which is at 8.71. MERY pays more dividend than 88.37% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, MERY pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.53%

5.2 History

The dividend of MERY decreases each year by -4.03%.
Dividend Growth(5Y)-4.03%
Div Incr Years3
Div Non Decr Years3
MERY.PA Yearly Dividends per shareMERY.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MERY pays out 102.93% of its income as dividend. This is not a sustainable payout ratio.
DP102.93%
EPS Next 2Y0.95%
EPS Next 3Y3.29%
MERY.PA Yearly Income VS Free CF VS DividendMERY.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
MERY.PA Dividend Payout.MERY.PA Dividend Payout, showing the Payout Ratio.MERY.PA Dividend Payout.PayoutRetained Earnings

MERCIALYS

EPA:MERY (3/7/2025, 7:00:00 PM)

10.58

+0.09 (+0.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)07-24 2025-07-24
Inst Owners43.83%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap993.36M
Analysts72.86
Price Target12.43 (17.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.53%
Yearly Dividend0.96
Dividend Growth(5Y)-4.03%
DP102.93%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.52%
PT rev (3m)-2.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.54%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE 10.91
Fwd PE 9.21
P/S 3.66
P/FCF 6.15
P/OCF 6.15
P/B 1.57
P/tB 1.58
EV/EBITDA 10.47
EPS(TTM)0.97
EY9.17%
EPS(NY)1.15
Fwd EY10.86%
FCF(TTM)1.72
FCFY16.26%
OCF(TTM)1.72
OCFY16.26%
SpS2.89
BVpS6.72
TBVpS6.68
PEG (NY)5.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 14.26%
ROCE 7.87%
ROIC 5.78%
ROICexc 6.71%
ROICexgc 6.73%
OM 59.47%
PM (TTM) 33.2%
GM 95.81%
FCFM 59.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.46%
OM growth 5Y-8.24%
PM growth 3Y-6.05%
PM growth 5Y-8.66%
GM growth 3Y1.08%
GM growth 5Y0.54%
F-Score8
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 8.07
Debt/EBITDA 6.51
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.73
Cash Conversion 84.02%
Profit Quality 179.46%
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z N/A
F-Score8
WACC7.7%
ROIC/WACC0.75
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)300.14%
Profit Quality(5y)255.17%
High Growth Momentum
Growth
EPS 1Y (TTM)7.53%
EPS 3Y-4.69%
EPS 5Y-9.96%
EPS Q2Q%1.75%
EPS Next Y2.05%
EPS Next 2Y0.95%
EPS Next 3Y3.29%
EPS Next 5YN/A
Revenue 1Y (TTM)1.85%
Revenue growth 3Y1.39%
Revenue growth 5Y-1.32%
Sales Q2Q%0.86%
Revenue Next Year1.68%
Revenue Next 2Y1.87%
Revenue Next 3Y1.88%
Revenue Next 5YN/A
EBIT growth 1Y30.33%
EBIT growth 3Y-10.23%
EBIT growth 5Y-9.45%
EBIT Next Year33.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.31%
FCF growth 3Y5.97%
FCF growth 5Y0.83%
OCF growth 1Y20.31%
OCF growth 3Y5.97%
OCF growth 5Y0.83%